http://www.farminglife.com/news/farming-news/the-disease-control-challenge-1-7548469
http://www.webbreakingnews.com/2016/08/28/merck-co-mrk-stake-lowered-by-gillespie-robinson-grimm-inc/
http://www.ssuchronicle.com/2016/08/30/pm360-announces-2016-trailblazer-award-finalists/
http://www.rttnews.com/2687305/biotech-stocks-facing-fda-decision-in-september.aspx
http://www.finanznachrichten.de/nachrichten-2016-08/38434003-biotech-stocks-facing-fda-decision-in-september-020.htm
http://www.scoop.co.nz/stories/HL1608/S00107/gordon-campbell-on-the-challenges-of-keytruda-funding.htm
http://www.irishsun.com/index.php/sid/247198857
http://www.4-traders.com//AMGEN-INC-4847/news/What-Amgen-Inc-NASDAQ-AMGN-Is-Saying-About-New-Repatha-Analyses-22975295/
http://www.emailwire.com/release/266982-Phosphodiesterase-Inhibitor-Market-Emerging-Trends.html
https://www.bostonglobe.com/business/2016/08/29/drug-companies-spending-more-unbranded-ads/o2nea8vQOprayqId3VhnnN/story.html
http://www.foxbusiness.com/features/2016/08/29/how-mylan-ceo-bresch-played-system.html
http://www.investopedia.com/news/zika-virus-vaccine-overturns-pharma-industry-playbook-gsk-sny-ion/
http://www.zawya.com/story/BlackRock_withheld_support_from_two_key_Exxon_directors-TR20160829nL1N1AX152X2/
http://www.reuters.com/article/us-exxon-directors-blackrock-idUSKCN11417F
http://www.moneycontrol.com/news/stocks-views/see-nuvaring-opportunity-for-dr-reddysq4fy18-credit-suisse_7359961.html
http://www.bizjournals.com/sanfrancisco/blog/biotech/2016/08/gilead-hepatitis-c-harvoni-sovaldi-minnesota.html
http://www.startribune.com/university-of-minnesota-sues-gilead-sciences-over-hepatitis-drugs/391796061/
http://theslot.jezebel.com/texas-district-attorney-im-here-to-tell-you-vaccines-1785947177
http://www.usnews.com/opinion/articles/2016-08-30/treat-epipen-and-generic-drugs-like-a-public-utility
http://www.eurekalert.org/pub_releases/2016-08/esoc-cui083016.php
http://www.lowcarboneconomy.com/profile/market_reseaarch_store/_news_and_press_releases/general_anxiety_disorder_market_worth_to_be_usd_3775_million_in_2020/38590
http://www.rundirectmagazine.com/angiotensin-converting-enzyme-ace-inhibitors-market-is-expected-to-grow-11094-6-mn-by-2023-credence-research/26022/
http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=11701824
http://www.investopedia.com/news/mylan-launch-cheaper-generic-epipen-myl/
http://247wallst.com/healthcare-business/2016/08/29/why-astrazeneca-could-gain-another-15-despite-market-headwinds/
http://www.finanznachrichten.de/nachrichten-2016-08/38429623-global-cathepsin-k-cathepsin-o-or-cathepsin-x-or-ec-3-4-22-38-therapeutics-pipeline-review-2016-research-and-markets-004.htm
http://www.snopes.com/2016/08/29/mylan-to-offer-generic-epipen/

http://www.xconomy.com/boston/2016/08/29/filing-moderna-blowing-past-record-450m-round-with-new-600m-raise/
http://www.eurekalert.org/pub_releases/2016-08/esoc-bo082916.php
http://www.prnewswire.com/news-releases/biolinerx-to-present-at-the-18th-annual-rodman--renshaw-global-investment-conference-in-new-york-591585301.html
http://www.emailwire.com/release/266445-Global-Market-Survey-Endocrinology-Drugindustry-Report-2016.html
http://www.radionz.co.nz/national/programmes/checkpoint/audio/201814201/pharmac-urged-to-fund-keytruda-for-other-cancers
http://www.koreaherald.com/view.php?ud=20160830000164

http://www.4-traders.com//news/Global-Histone-Deacetylase-3-SMAP45-or-EC-3-5-1-98-Therapeutics-Pipeline-Review-H1-2016-Researc--22971653/
http://www.4-traders.com//news/Global-HIV-1-Integrase-EC-2-7-7-Pipeline-Review-2016-Research-and-Markets--22971681/

http://www.4-traders.com//news/Peripheral-Nerve-Sheath-Tumor-Neurofibrosarcoma-Market-Pipeline-Review-Report-H1-2016-Research--22971309/

